Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial by Silk, Sarah E, Kalinga, Wilmina F, Salkeld, Jo, Mtaka, Ivanny M, Ahmed, Saumu, Milando, Florence, Diouf, Ababacar, Bundi, Caroline K, Balige, Neema, Hassan, Omar, Mkindi, Catherine G, Rwezaula, Stella, Athumani, Thabit, Mswata, Sarah, Lilolime, Nasoro S, Simon, Beatus, Msami, Hania, Mohamed, Mohamed, David, Damiano M, Mohammed, Latipha, Nyaulingo, Gloria, Mwalimu, Bakari, Juma, Omary, Mwamlima, Tunu G, Sasamalo, Ibrahim A, Mkumbange, Rose P, Kamage, Janeth J, Barrett, Jordan R, King, Lloyd D W, Hou, Mimi M, Pulido, David, Carnrot, Cecilia, Lawrie, Alison M, Cowan, Rachel E, Nugent, Fay L, Roberts, Rachel, Cho, Jee-Sun, Long, Carole A, Nielsen, Carolyn M, Miura, Kazutoyo, Draper, Simon J, Olotu, Ally I, Minassian, Angela M

Get full text